Curaleaf Price Target

TSE:CURA's price target is C$16. Does Vitamin Shoppe Sells Indian Hemp Hair Oil - Hemp Trailz Cbd Oil Vape Pen Hemp Oil Projected Sales Does Vitamin Shoppe Sells Indian Hemp Hair Oil Can Cbd Hemp Oil Help Insomnia From Adrenal Fatigue While everyone of these methods will work great to remove yeast infection symptoms fast, they are nevertheless but a part of an overall natural infections treatment. 75 Canadian dollars. Curaleaf's CEO, Joseph Lusardi, said, "Our industry needs, wants and appreciates the work the FDA is doing to ensure there is regulation and compliance in the CBD marketplace. Curaleaf is present in 12 U. Curaleaf’s stock peaked at about $15 in May but had been trending downward, losing more than 45 per cent of its value in two months. 6% as of 2:22 p. Curaleaf enjoys another distinction: it's the largest publicly traded retail chain of marijuana products in the U. Green Thumb Industries with a $18. 85B and has a P/E ratio of -. (GTBIF) at outperform with a stock price target of $18. 25 a share around 1 p. Curaleaf is committed to being the industry's leading resource in education and advancement through research and advocacy. Grassroots Cannabis is set to be acquired for $875 million, becoming the latest Chicago-based marijuana company to draw a blockbuster price tag from an out-of-state operator. Our Curaleaf Holdings Inc (CURA) consensus estimates gives you the next 12-Months price consensus forecasts, based on industry's top analysts. Select Aquisition In May, Curaleaf said it was going to acquire Cura Partners, Inc. The average analyst target price of $19. Boris Jordan, Curaleaf executive chairman, joins 'Squawk on the Street' to discuss Curaleaf's acquisition of Cura Partners, the parent of the Select brand, and what it will mean for the industry. 50 at Cowen MarketWatch. Curaleaf’s multi-state operations now access a total U. Curaleaf (CURA), who is currently licensed in the state of Maryland has offered to buy a competitor’s licenses for upward of $30 million. 50, and $10. 50, Curaleaf Holdings Inc. Curaleaf drops the most this year after FDA targets its CBD products The Wakefield, Massachusetts-based company's share price plunged more than 14 per cent on Tuesday, the biggest drop this. 00 target would mean a 120 percent or so increase in strong price from its current position. Select Aquisition In May, Curaleaf said it was going to acquire Cura Partners, Inc. With an average price target of $15, analysts clearly think the stock could double in the next 12 months. “We use a target multiple of 25x, and an exchange rate of 0. Curaleaf (CURA) reported its second-quarter earnings on Tuesday. Curaleaf trades at a premium of 75. The company is called Curaleaf Holdings (OTCBB: CURLF), and not only does it operate four of the most successful medical cannabis dispensaries in New York, but it also actually has the largest footprint of branded retail stores in the U. View a stock's price, volume, volatility and other statistics, as well as a price chart, news, performance vs. As soon as we walked in, we had a friendly man that helped enter our info for the first time. CURLF / Curaleaf Holdings Inc short volume is shown in the following chart. MKM starts Curaleaf at… MKM starts Curaleaf at Sell on concerns over Florida dependency. This deal was done in Stock. 30, that puts the total purchase price at C$1. Cowen initiated coverage on shares of Curaleaf (OTCMKTS:CURLF) in a research note issued on Friday, The Fly reports. Takeaway The key investor takeaway is that Curaleaf is building a cannabis market leader under the radar of most investors even in the cannabis sector. (To watch Hundley's track record, click here) Hundley commented, "We view any weakness in CURLF shares as near-term buying opportunities for investors. 83 billion) in Cronos. 67, which represents ~98% increase from current levels. With analysts giving the company a price target of $25, that would give today's investors an increase of 200% as of writing. The firm's 50-day simple moving average is $7. Massachusetts-based Curaleaf, a vertically integrated cannabis company, is seeking a valuation of up to $4 billion. cannabis market. cannabis retailer Curaleaf Holdings Inc is raising about $400 million, almost three times its original target, in Toronto, in a deal that would value the company at close to $4 billion. Updated stock price target summary. Meanwhile, Aphria has mostly “strong buy” ratings on its stock and a target price of 14. 299 CAD Highest Target 25. Based on these reviews, shares of Curaleaf hold an average price target of C$16. Separately, Compass Point began coverage on Curaleaf in a report on Monday, June 10th. Boris Jordan, Curaleaf executive chairman, joins 'Squawk on the Street' to discuss Curaleaf's acquisition of Cura Partners, the parent of the Select brand, and what it will mean for the industry. 50 stock price target at Cowen MarketWatch. Grassroots Cannabis is set to be acquired for $875 million, becoming the latest Chicago-based marijuana company to draw a blockbuster price tag from an out-of-state operator. The average price target among these analysts stands at $19. com - Curaleaf slumped in midday trade Tuesday after receiving a warning letter from the Federal Drug Administration over its promotion of unapproved products containing cannabidiol (CBD). Curaleaf offers multiple products under three brands: Curaleaf, Curaleaf Hemp, and UKU Craft Cannabis. of Brokers 8 Median Target 19. 50 "CURA boasts the highest revenue base in our coverage, leading gross margins and has two attractive M&A opportunities to scale even further. CURLF - Curaleaf Holdings Inc Stock quote - CNNMoney. Westleaf (WL. Curaleaf Holdings, Inc. Curaleaf launched its first New York medical marijuana dispensary in Newburgh with an open house and tour on Thursday. Advocacy leaders. (To watch Hundley’s track record, click here) Hundley commented, “We view any weakness in CURLF shares as near-term buying opportunities for investors. 8% from its low of 5. A cash flow statement is a financial statement that summarizes the amount of cash and cash equivalents entering and leaving a company. Curaleaf (CURA), who is currently licensed in the state of Maryland has offered to buy a competitor’s licenses for upward of $30 million. The cash flow statement measures how well a company manages its cash position, meaning how well the company generates cash to pay its debt obligations and fund its operating expenses. His target price is $13 and the stock was lately trading at $7. HMUS seeks to replicate, to the extent possible, the performance of the US Marijuana Companies Index, net of expenses. (CRLBF) at outperform with a $14 target. Find real-time CURLF - Curaleaf Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. It opened at C$9. 4% MarketWatch. Curaleaf says that the acquisition will make it the world’s largest cannabis company by revenue and one of the largest operators in the United States. Citi's Mark May - Buy. The high price target for CURLF is $11. Curaleaf is the first company to offer medical cannabis tablets in Florida. C), which is and has long been a client for this website, is decrepit. He doubled down on his "buy" rating for Curaleaf, with a target price of $11, up around 50 percent from its current levels. Their average twelve-month price target is $8. Massachusetts-based Curaleaf made its trading debut on the Canadian Securities Exchange on Monday after a $400 million private placement. “This is an impressive feat considering this was Valens’ second quarter of operations and capacity utilization remains low at ~8% of the recently expanded 425 tonnes,” Macdonell wrote in a note to clients. This was the third straight month of double-digit sales growth! This growth will continue. The size, reach, and future scalability of Curaleaf cannot be ignored. 5(a) of MI 61-101 – Issuer Not Listed on Specified Markets and 5. This cannabis store is here to service Wellington, West Palm Beach, Boynton Beach, and Palm Beach County in general. Prior to the deal, Stanley held a $23 price target but. 00 from C$9. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area, lines. The deal resulted in a sorely needed boost — one that that has Stanley feeling even more bullish about the company's future. Curaleaf's share price decreased by more than 13 percent on Tuesday and closed at C$9. 8), or 36% below its current trading level. Curaleaf started at outperform with $10. Curaleaf is the first company to offer medical cannabis tablets in Florida. Prior to the deal, Stanley held a $23 price target but. " Analysts' view Following the company's announcement, Canaccord Genuity raised the target price Curaleaf stock to 16 Canadian dollars from 14 Canadian dollars. Azer started Green Thumb Industries Inc. Curaleaf Stock Stumbles as Multi-State Landscape Gets Crowded. Updated stock price target summary. This was the third straight month of double-digit sales growth! This growth will continue. Curaleaf Hldgs Inc. The letter is currently under review by our legal counsel," the company. Cronos is a Canadian cannabis supplier based in Ontario. The Wakefield, Massachusetts-based company's share price plunged more than 14% on Tuesday, before paring the losses. The company's shares closed last Monday at $7. The deal resulted in a sorely needed boost — one that that has Stanley feeling even more bullish about the company's future. 99 and a low estimate of $3. 67, which represents ~98% increase from current levels. Here is a breakdown of the current landscape and some up-and-comers to. Lake Worth - A Curaleaf dispensary is now open at 1125 N Dixie Hwy in zip code 33460 to help medical cannabis patients get relief through a range of medical marijuana products. Member FINRA / SIPC. DOW JONES, A NEWS CORP COMPANY News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Curaleaf's CEO, Joseph Lusardi, said, "Our industry needs, wants and appreciates the work the FDA is doing to ensure there is regulation and compliance in the CBD marketplace. Curaleaf Holdings stock opened at $8. This cannabis store is here to service Wellington, West Palm Beach, Boynton Beach, and Palm Beach County in general. MKM starts Curaleaf at… MKM starts Curaleaf at Sell on concerns over Florida dependency. L) also gained 9%. Shares were down about 5. In a press released. 50 and a rating of outperform while initiating coverage on the company. Curaleaf Holdings Inc, formerly known as Lead Ventures Inc, is a Canada-based vertically integrated cannabis operator in the United States. Curaleaf is Top Cannabis Stock Pick from Cormark Institutional Equity Research Analyst Jesse Pytlak. Detailed price information for Curaleaf Holdings Inc (CURA-CN) from The Globe and Mail including charting and trades. 3, 2019 /PRNewswire/ — Curaleaf Holdings, Inc. Curaleaf stock down 7. The company embarking on an aggressive acquisition drive has continued to excite investors, a development that has seen the share price nearly double in value. The analyst reiterated his buy rating on the stock and C$24 price target that is almost three times its current trading level. 28 million and a net loss of $0. 8), or 36% below its current trading level. Curaleaf Holdings stock opened at $8. Meanwhile, Aphria has mostly “strong buy” ratings on its stock and a target price of 14. Curaleaf Holdings, Inc. and the company is only going to cement their dominance after its groundbreaking deal with pharmacy chain giant CVS in March this year. The company is called Curaleaf Holdings (OTCBB: CURLF), and not only does it operate four of the most successful medical cannabis dispensaries in New York, but it also actually has the largest footprint of branded retail stores in the U. The 3-month volatility stands at 74. Lake Worth - A Curaleaf dispensary is now open at 1125 N Dixie Hwy in zip code 33460 to help medical cannabis patients get relief through a range of medical marijuana products. Curaleaf trades at a premium of 75. stock quote and CURLF charts. The Massachusetts-based firm debuted under the symbol "CURA" and was trading at $9. Our Curaleaf Holdings Inc (CURA) consensus estimates gives you the next 12-Months price consensus forecasts, based on industry's top analysts. Saturday, Sep 28, 2019. To know more about Curaleaf’s valuation, read Curaleaf: Target Price and Valuation Multiple after Q2. Inton says Altria. Jesse Pytlak, I have a C$15 target price on this stock. 857400 (decimal). 3, 2019 /CNW/ -- Curaleaf Holdings, Inc. analyst Vivien Azer initiated coverage of MedMen Enterprises on Friday with an Underperform rating and a price target of US$1. The company reported a net loss of $0. cannabis company with experienced management, access to capital and a demonstrated growth strategy. 6% as of 2:22 p. Curaleaf Holdings Inc, formerly known as Lead Ventures Inc, is a Canada-based vertically integrated cannabis operator in the United States. 06% at outperform with a $10. The price target for medmen (MMEN) is incorrect. Pinterest stock price target cut to $31 from. Being a multi-state operator, its revenue will likely grow at a far greater rate than competitors. CD : Haywood Securities cuts target to C$17. Curaleaf Holdings Inc, formerly known as Lead Ventures Inc, is a Canada-based vertically integrated cannabis operator in the United States. Meanwhile, Congress is presently holding serious hearings to end cannabis Prohibition at the federal level. Curaleaf's share price decreased by more than 13 percent on Tuesday and closed at C$9. For an analyst ratings summary. 99 and a low estimate of $3. With Curaleaf an established cannabis leader, Lusardi and his team are doubling down on the advocacy and policy work that is a pillar of the company's ethos. Curaleaf is the first company to offer medical cannabis tablets in Florida. 27 billion or $948. MedMen ( MMNFF ) received the bearish call. ET by Ciara Linnane. The marijuana sector has been a poor performing sector this year so I wouldn't press too hard on it, but there are still a few catalysts left this year that could help the US MSO's take a run. Prior to the deal, Stanley held a $23 price target but has since raised it to $25. The company is called Curaleaf Holdings (OTCBB: CURLF), and not only does it operate four of the most successful medical cannabis dispensaries in New York, but it also actually has the largest footprint of branded retail stores in the U. WAKEFIELD, Mass. Kirk rates Curaleaf's Canada-listed stock a sell and has a stock price target of C$5 ($3. 9 Canadian dollars. 50, which is still a decent premium over the near US$8 a share that the stock has been trading at on the OTC market. However, in order to maintain the high level of discours. The company’s total sales reached $45. 22, 2019 at 2:01 p. With an average price target of $15, analysts clearly think the stock could double in the next 12 months. Got another?. Over the past three months, there have been four upgrades to "buy" with a one-year price target of $15. Curaleaf stock price target cut to $9. 1% in the last two days. Acreage, Curaleaf Will Benefit From New Jersey Market New Jersey is moving ahead with legislation to legalize adult-use marijuana. Low Target. Curaleaf has announced that it struck an acquisition deal worth $70 million for Acres Cannabis which runs cannabis cultivation facilities as well as extraction and production labs. 5(a) of MI 61-101 – Issuer Not Listed on Specified Markets and 5. With analysts giving the company a price target of $25, that would give today's investors an increase of 200% as of writing. Curaleaf Florida provides Florida patients pharmaceutical-grade, standardized-dose medical cannabis to improve health and well-being. The CURALEAF HOLDINGS INC Equities Center is a collection of modules for CURALEAF HOLDINGS equity research and analysis. Curaleaf Holdings Inc's market cap is currently C$2. A cash flow statement is a financial statement that summarizes the amount of cash and cash equivalents entering and leaving a company. Prior to the deal, Stanley held a $23 price target but. Curaleaf's latest large scale acquisition fell just outside the quarterly reporting time frame, as the deal to acquire private MSO company Grassroots was announced earlier this summer. Curaleaf stock down 7. CURLF:OTCQX OTCQX Established, investor-focused US and global companies that meet high financial standards, are not Penny Stocks and are current in their. the owners of the Oregon-based Select brand, in an all-stock deal valued at C$1. 67, which represents ~98% increase from current levels. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is the leading vertically integrated multi-state cannabis operator in the United States. Here is a breakdown of the current landscape and some up-and-comers to. This is 190% above Curaleaf's current price of $8. CURLF / Curaleaf Holdings Inc short volume is shown in the following chart. Based on a closing price Tuesday of C$13. Prior to the deal, Stanley held a $23 price target but has since raised it to $25. 03 Canadian dollars. Curaleaf Holdings Inc's market cap is currently C$2. Trulieve Cannabis (TRUL) has opened a new dispensary in Florida. Curaleaf is committed to being the industry's leading resource in education and advancement through research and advocacy. Aurora, with a funded production capacity in excess of 570,000 kg per year combined with a rapidly growing domestic and international sales and operat. This deal was done in Stock. With Curaleaf an established cannabis leader, Lusardi and his team are doubling down on the advocacy and policy work that is a pillar of the company’s ethos. Stanley has a target price of $25 for Curaleaf. 88 with a high estimate of $18. 50; While current price targets leave little room for share price appreciation on equities such as Acreage Holdings and Curaleaf Holdings, the standout in terms of rating and price targets is that of Medmen Enterprises and their $1. 00 target price on the stock. Curaleaf’s revenue growth is on fire as the company expands. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, today announced that it will report its financial and operating results for the second quarter ended June 30, 2019 after market close on August 29, 2019. population base of 177 million people. The best long-term & short-term Curaleaf Holdings share. CURA currently trades at 6. Cannabis stocks turn higher after Curaleaf misses revenue estimates but offers bullish outlook The analyst reiterated his buy rating on the stock and C$24 price target that is almost three. Azer started Green Thumb Industries Inc. View CURLF revenue estimates and earnings estimates, as well as analyst recommendations. Curaleaf will acquire Grassroots for total consideration of approximately $875 million, composed of $75 million in cash, 102. 50, and $10. 50 per share price target. Curaleaf Holdings Inc (OTCMKTS: CURLF) stock price continues to grow sharply as investors react to a string of strategic investments that position the company for robust growth. Curaleaf Stock Stumbles as Multi-State Landscape Gets Crowded. 5 million in 2019, and his ambitious C$20. While this stock might not have as high a target price as Curaleaf, it certainly has the triple-digit growth in share price. 50 stock price target at Cowen MarketWatch. The analyst reiterates a Buy rating on Curaleaf stock, with a price target of $11. See CURLF price target based on 4 analysts offering 12 month price targets for Curaleaf Holdings Inc (CURLF) in the last 3 months. Curaleaf drops the most this year after FDA targets its CBD products The Wakefield, Massachusetts-based company's share price plunged more than 14 per cent on Tuesday, the biggest drop this. Curaleaf Holdings (CURLF), with a price target of $10. The high THC is fantastic for triggering the munchies and suppressing the urge to vomit. and the company is only going to cement their dominance after its groundbreaking deal with pharmacy chain giant CVS in March this year. (OTC: CURLF) (CSE:CURA) said Wednesday it has entered into an agreement to acquire multi-state operator Grassroots for $875 million in cash and stock. Current Target Price. “This is an impressive feat considering this was Valens’ second quarter of operations and capacity utilization remains low at ~8% of the recently expanded 425 tonnes,” Macdonell wrote in a note to clients. Using equity center you examine different market driven as well as company specific characteristics using powerful technical, fundamental, predictive and other CURALEAF HOLDINGS INC specific modules. Cormark also raised its price target to CDN$18 a share, from $15, calling Curaleaf a "must-own" US cannabis name. (CURLF) stock price, charts, trades & the US's most popular discussion forums. Curaleaf only trades at about 6x the 2021 EBITDA target with the stock back down closer to $7 after topping $8 on the Grassroots deal. Based on 4 analysts offering 12 month price targets for TSE:CURA in the last 3 months. Aurora, with a funded production capacity in excess of 570,000 kg per year combined with a rapidly growing domestic and international sales and operat. Their success stems from owning the largest footprint of single-branded retail stores in the U. 50; Medmen Enterprises – Underperform – Price target: $1. This deal was done in Stock. On the growing CBD side of the industry, Curaleaf is currently focused on in-house operations with the Curaleaf Hemp spin-off. On May 1, 2019, Curaleaf announced signing a definitive agreement to acquire Select's business. Additionally, Curaleaf is a vertically integrated cannabis company. The average analyst target price of $19. 22, 2019 at 2:01 p. 8), or 36% below its current trading level. Find real-time CURLF - Curaleaf Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. 50, which is still a decent premium over the near US$8 a share that the stock has been trading at on the OTC market. Kirk rates Curaleaf’s Canada-listed stock a sell and has a stock price target of C$5 ($3. Green Thumb Industries with a $18. (CURLF) at outperform with a $10. Medmen Enterprises - Underperform - Price target: $1. 000 CAD Lowest Target 14. TSE:CURA's price target is C$16. Currently, the company trades at a discount of 42. Stanley has a target price of $25 for Curaleaf. The high price target for CURLF is $11. Lake Worth - A Curaleaf dispensary is now open at 1125 N Dixie Hwy in zip code 33460 to help medical cannabis patients get relief through a range of medical marijuana products. Prior to the deal, Stanley held a $23 price target but has since raised it to $25. 85B and has a P/E ratio of -. (To watch Hundley’s track record, click here) Hundley commented, “We view any weakness in CURLF shares as near-term buying opportunities for investors. 00, which implies nearly 50% upside from current levels. Find real-time CURLF - Curaleaf Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. Toronto | Reuters – U. 00 target price. 50 and a rating of outperform while initiating coverage on the company. 88 with a high estimate of $18. multiple, which generates our price target of $13. 50, Curaleaf Holdings Inc. I think that's a bit too optimistic. Price target in 14 days: 6. 1 million through the first nine months of fiscal 2018, compared to $13 million through the first nine months of 2017. the owners of the Oregon-based Select brand, in an all-stock deal valued at C$1. Saturday, Sep 28, 2019. 28 million and a net loss of $0. (CURLF) stock price, charts, trades & the US's most popular discussion forums. The best long-term & short-term Curaleaf Holdings share. (CSE:CURA) (OTC:CURLF) with a bullish buy rating and a frothy price target that suggests shares of Curaleaf may double from. " Analysts' view Following the company's announcement, Canaccord Genuity raised the target price Curaleaf stock to 16 Canadian dollars from 14 Canadian dollars. WAKEFIELD, Mass. multistate operators. He is not alone. 76 USD/CAD, applied to our 2020 EBITDA forecast of $297 million to derive our C$20. 30, that puts the total purchase price at C$1. The CURALEAF HOLDINGS INC Equities Center is a collection of modules for CURALEAF HOLDINGS equity research and analysis. Cronos has mostly "hold" ratings and a target price of 20. Curaleaf reaffirmed its FY 2019 outlook for managed revenue of $400 million and free cash flow of $100 million. that price can drop down to about 7 cents per milligram. Latest stock price today and the US's most active stock market forums. 00, which implies nearly 50% upside from current levels. Cricket Valley Energy Center on target for 2020 open. Azer started Green Thumb Industries Inc. Curaleaf Florida provides Florida patients pharmaceutical-grade, standardized-dose medical cannabis to improve health and well-being. It is a high-growth cannabis company with a. Curaleaf Stock Stumbles as Multi-State Landscape Gets Crowded. I think that's a bit too optimistic. 00, which implies nearly 50% upside from current levels. 455 CAD Analyst Opinions for Curaleaf. 50, and $10. To read more on the nitty gritty of what's going on in the rising cannabis. -listed shares rose 9%, while the Canadian (CURA. 50, Curaleaf Holdings Inc. 6% as of 2:22 p. "We use a target multiple of 25x, and an exchange rate of 0. 3% since then. (GTBIF) at outperform with a stock price target of $18. 50 at Cowen MarketWatch. Find a dispensary near you and start living life well today. View a stock's price, volume, volatility and other statistics, as well as a price chart, news, performance vs. The company reported a net loss of $0. 31, representing an almost 9 percent value increase. Curaleaf stock price target cut to $9. To know more about Curaleaf’s valuation, read Curaleaf: Target Price and Valuation Multiple after Q2. Share price weakness plus a number of upcoming catalysts make Curaleaf Holdings stock a buy, says analyst Robert Fagan of GMP Securities, He has raised his one-year price target on the stock. The stock remains far under the radar of investors based on followers on financial websites. 50 per share price target. (GTBIF) at outperform with a stock price target of $18. The company has operations in 19 states, including the assets from the Cura Select and Grassroots acquisitions. On the growing CBD side of the industry, Curaleaf is currently focused on in-house operations with the Curaleaf Hemp spin-off. 27 billion, or US$948. , a multi-state cannabis operator based out of Massachusetts announced on Wednesday the company signed a blockbuster deal to acquire cannabis oil company Cura Partners in an all-stock transaction worth CA$1. 88 with a high estimate of $18. Our Curaleaf Holdings Inc (CURA) consensus estimates gives you the next 12-Months price consensus forecasts, based on industry's top analysts. Curaleaf Arizona provides Arizona patients pharmaceutical-grade, standardized-dose medical cannabis to improve health and well-being. (CSE: CURA /OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States , today announced that on Friday, September 27, 2019 Executive Chairman Boris Jordan purchased 100,000 shares of Curaleaf stock on the open market at an average price of $8. Member FINRA / SIPC. 89162 50/200 day moving average cross. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area, lines. ” Analysts’ view Following the company’s announcement, Canaccord Genuity raised the target price Curaleaf stock to 16 Canadian dollars from 14 Canadian dollars. 27 billion or $948. 8), or 36% below its current trading level. Curaleaf is on a path to lead the cannabis market in revenues. Based on normal probability distribution, the odds of CURALEAF HOLDINGS to move above current price in 30 days from now is about 41. 25 a share around 1 p. Curaleaf Holdings, Inc. Additionally, Curaleaf is a vertically integrated cannabis company. (CSE:CURA) (OTC:CURLF) with a bullish buy rating and a frothy price target that suggests shares of Curaleaf may double from. Curaleaf enjoys another distinction: it's the largest publicly traded retail chain of marijuana products in the U. The revenue target maintains similar guidance made back in November, meaning it achieved most or all of its operational benchmarks for the quarter. 11:27 AM ET. 28 million and a net loss of $0. Curaleaf is present in 12 U. Over the past three months, there have been four upgrades to "buy" with a one-year price target of $15.